Global Chemotherapy Drugs Market to expand with over 11% CAGR through 2023

November 08, 2019


According to the latest study titled ‘Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)’ available with Market Study Report LLC, the global chemotherapy drugs market is estimated to grow with a CAGR of 11.91% during 2018-2023.  
 

Chemotherapy is a treatment to preclude the growth of cancer cells. The chemotherapy drugs prevent further multiplication of cancer cells and shrink the tumor cells, thereby increasing the life span of patient suffering from cancer. Prevalence of various types of cancers among the global population, coupled with increasing awareness regarding cancer treatments are propelling the growth of chemotherapy drugs market. Other factors aiding the market growth are improved healthcare infrastructure, rising medical expenditure, and availability of medical insurances.
 

The study examines the market for revenue shares and growth opportunities for different segments. Moreover, it provides an exhaustive understanding about drivers, challenges and restraints influencing the market growth. 

Based on drug type, the chemotherapy drugs market is segmented into plant alkaloids, antimetabolites, antitumor antibiotics, alkylating agents, and others. The significant growth witnessed by these drug segments can be attributed to their applicability for the treatment of several cancers and solid tumors.

Speaking of administration route, chemotherapy drugs industry is divided into oral, intravenous, and others. While, considering the geographical landscape, the market is fragmented into four major regions, namely, Europe, North America, APAC, and rest of the world, with key focus on countries like Canada, U.S., Germany, United Kingdom, India, and China.

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1856957/

As per the report, North America registered the largest regional share in the global chemotherapy drugs market in 2018, whereas APAC region is predicted to gain momentous growth over the forecast timeline, owing to fostering pharmaceutical sector, rising incidences of cancer, along with government’s focus on developing medical infrastructural.

Some of the vendors that operate in chemotherapy drugs market are Eli Lilly & Company, Pfizer, Bristol-Myers Squibb, Celgene Corporation, Merck & Co. Inc., Novartis, GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, and Sanofi.


Frequently Asked Questions (FAQ) :

Prevalence of various types of cancers among the global population, coupled with increasing awareness regarding cancer treatments are propelling the growth of chemotherapy drugs market. Other factors aiding the market growth are improved healthcare infrastructure, rising medical expenditure, and availability of medical insurances.
The global chemotherapy drugs market is estimated to grow with a CAGR of 11.91% through 2023.
As per the report, North America registered the largest regional share in the global chemotherapy drugs market in 2018.
Companies that operate in chemotherapy drugs market are Eli Lilly & Company, Pfizer, Bristol-Myers Squibb, Celgene Corporation, Merck & Co. Inc., Novartis, GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, and Sanofi.